Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 07-Nov-25 | 10294.40 | 2.94% | - | 1.06% | 10/230 |
| 1 Month | 14-Oct-25 | 10353.00 | 3.53% | - | 2.14% | 42/226 |
| 3 Month | 14-Aug-25 | 10288.80 | 2.89% | - | 4.73% | 176/224 |
| 6 Month | 14-May-25 | 10648.90 | 6.49% | - | 8.05% | 137/214 |
| YTD | 01-Jan-25 | 9769.00 | -2.31% | - | 5.51% | 171/201 |
| 1 Year | 14-Nov-24 | 10529.30 | 5.29% | 5.29% | 8.71% | 131/187 |
| 2 Year | 13-Nov-23 | 14742.70 | 47.43% | 21.35% | 20.48% | 60/141 |
| Since Inception | 14-Dec-22 | 17647.40 | 76.47% | 21.47% | 14.34% | 35/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 14-Nov-24 | 12000 | 12625.26 | 5.21 % | 9.77 % |
| 2 Year | 13-Nov-23 | 24000 | 26934.25 | 12.23 % | 11.49 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 201.4 | 22.18% | 0.57% | 25.51% (Apr 2025) | 21.61% (Sep 2025) | 1.19 L | -0.25 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 96.8 | 10.66% | 1.36% | 11.01% (May 2025) | 9.3% (Sep 2025) | 14.36 k | -27.00 |
| Cipla Ltd. | Pharmaceuticals | 95.5 | 10.51% | -0.37% | 11.42% (Aug 2025) | 10.2% (Dec 2024) | 63.59 k | -0.13 k |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 82.5 | 9.08% | -0.51% | 10.28% (Dec 2024) | 9.08% (Oct 2025) | 68.88 k | -0.14 k |
| Lupin Ltd. | Pharmaceuticals | 53.7 | 5.91% | -0.03% | 6.89% (Dec 2024) | 5.7% (Jul 2025) | 27.35 k | -56.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 42.1 | 4.64% | -0.21% | 4.85% (Sep 2025) | 3.83% (Dec 2024) | 11.83 k | -21.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 41.9 | 4.61% | 0.41% | 4.61% (Oct 2025) | 2.87% (Nov 2024) | 43.92 k | -89.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 36 | 3.97% | 0.07% | 4.55% (Nov 2024) | 3.67% (Aug 2025) | 31.62 k | -63.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 35.1 | 3.86% | -0.07% | 3.93% (Sep 2025) | 3.31% (Jul 2025) | 6.37 k | -9.00 |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 32.2 | 3.55% | -0.24% | 3.93% (Jul 2025) | 2.69% (Apr 2025) | 17.03 k | -33.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.67% |
| Net Receivables | Net Receivables | -0.65% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 4.21 | 14.03 | 46.24 | 44.70 | 37.87 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | -0.58 | 2.66 | 16.83 | 29.79 | 15.87 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 297.12 | 5.18 | 10.51 | 19.92 | 26.94 | 14.82 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 680.73 | 4.78 | 9.14 | 20.47 | 26.41 | 0.00 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1733.63 | 0.21 | 10.07 | 21.28 | 24.40 | 0.00 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 3.74 | 4.50 | 14.80 | 24.22 | 18.39 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 5.07 | 8.69 | 9.87 | 23.19 | 15.72 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7556.72 | 1.80 | 5.87 | 11.55 | 23.19 | 0.00 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 4.25 | 6.87 | 12.25 | 22.89 | 21.04 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1518.73 | 3.04 | 7.71 | 8.90 | 22.66 | 0.00 |
Out of 109 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 9 is/are ranked 3 * , 5 is/are ranked 2 * , 3 is/are ranked 1 * , and 78 schemes are not ranked. See more about AMC